{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,21]],"date-time":"2026-06-21T04:48:16Z","timestamp":1782017296895,"version":"3.54.5"},"reference-count":98,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,19]],"date-time":"2026-01-19T00:00:00Z","timestamp":1768780800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000025","name":"National Institute of Mental Health","doi-asserted-by":"publisher","award":["R01 R01MH113617"],"award-info":[{"award-number":["R01 R01MH113617"]}],"id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Schizophrenia Research"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.schres.2026.01.006","type":"journal-article","created":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T13:54:36Z","timestamp":1768485276000},"page":"33-45","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Randomized double-blind inpatient study of a gluten-free diet for negative symptoms in people with schizophrenia"],"prefix":"10.1016","volume":"289","author":[{"given":"Deanna L.","family":"Kelly","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher M.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gopal","family":"Vyas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert W.","family":"Buchanan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel J.","family":"Roche","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valerie","family":"Harrington","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura M.","family":"Rowland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S. Andrea","family":"Wijtenburg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bhim M.","family":"Adhikari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Korrapati V.","family":"Sathyasaikumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Kochunov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monica V.","family":"Talor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Waltz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie","family":"Hare","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heather A.","family":"Adams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Schwarcz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deepak","family":"Salem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James M.","family":"Gold","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah M.","family":"Clark","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William W.","family":"Eaton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.schres.2026.01.006_bb0005","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.jpsychires.2017.11.004","article-title":"Schizophrenia heterogeneity revisited: clinical, cognitive, and psychosocial correlates of statistically-derived negative symptoms subgroups","volume":"97","author":"Ahmed","year":"2018","journal-title":"J. Psychiatr. Res."},{"issue":"7","key":"10.1016\/j.schres.2026.01.006_bb0010","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1001\/archpsyc.1982.04290070020005","article-title":"Negative symptoms in schizophrenia. Definition and reliability","volume":"39","author":"Andreasen","year":"1982","journal-title":"Arch. Gen. Psychiatry"},{"issue":"7","key":"10.1016\/j.schres.2026.01.006_bb0015","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1001\/archpsyc.1982.04290070025006","article-title":"Negative v positive schizophrenia. Definition and validation","volume":"39","author":"Andreasen","year":"1982","journal-title":"Arch. Gen. Psychiatry"},{"issue":"1","key":"10.1016\/j.schres.2026.01.006_bb0020","doi-asserted-by":"crossref","first-page":"6487","DOI":"10.1038\/s41598-021-85052-5","article-title":"The holding temperature of blood during a delay to processing can affect serum and plasma protein measurements","volume":"11","author":"Ashworth","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.schres.2026.01.006_bb0025","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1192\/bjp.154.5.672","article-title":"A rating scale for drug-induced akathisia","volume":"154","author":"Barnes","year":"1989","journal-title":"Br.J.Psychiatry"},{"issue":"4","key":"10.1016\/j.schres.2026.01.006_bb0030","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1177\/0269881103174013","article-title":"The Barnes Akathisia rating scale\u2013revisited","volume":"17","author":"Barnes","year":"2003","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.schres.2026.01.006_bb0035","series-title":"Principles and Practice of Infectious Diseases","first-page":"34","article-title":"Adaptive immunity: antibodies and immunodeficiencies","author":"Birdsall","year":"2015"},{"issue":"3","key":"10.1016\/j.schres.2026.01.006_bb0040","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/0165-1781(89)90148-0","article-title":"The Neurological Evaluation Scale (NES): a structured instrument for the assessment of neurological signs in schizophrenia","volume":"27","author":"Buchanan","year":"1989","journal-title":"Psychiatry Res."},{"issue":"4","key":"10.1016\/j.schres.2026.01.006_bb0045","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1093\/schbul\/sbu151","article-title":"Rasagiline in the treatment of the persistent negative symptoms of schizophrenia","volume":"41","author":"Buchanan","year":"2015","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.schres.2026.01.006_bb0050","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.neubiorev.2021.01.018","article-title":"Dysregulation of kynurenine pathway and potential dynamic changes of kynurenine in schizophrenia: a systematic review and meta-analysis","volume":"123","author":"Cao","year":"2021","journal-title":"Neurosci. Biobehav. Rev."},{"issue":"2","key":"10.1016\/j.schres.2026.01.006_bb0055","doi-asserted-by":"crossref","first-page":"319","DOI":"10.14309\/ajg.0000000000001565","article-title":"Plasma IL-2 and symptoms response after acute gluten exposure in subjects with celiac disease or nonceliac gluten sensitivity","volume":"117","author":"Cartee","year":"2022","journal-title":"Am. J. Gastroenterol."},{"issue":"1","key":"10.1016\/j.schres.2026.01.006_bb0060","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1093\/ajcn\/85.1.160","article-title":"A prospective, double-blind, placebo-controlled trial to establish a safe gluten threshold for patients with celiac disease","volume":"85","author":"Catassi","year":"2007","journal-title":"Am. J. Clin. Nutr."},{"issue":"1","key":"10.1016\/j.schres.2026.01.006_bb0065","article-title":"Prevalence of schizophrenia in China between 1990 and 2010","volume":"5","author":"Chan","year":"2015","journal-title":"J. Glob. Health"},{"issue":"3","key":"10.1016\/j.schres.2026.01.006_bb0070","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1007\/s11481-013-9460-x","article-title":"Magnetic resonance spectroscopy to assess neuroinflammation and neuropathic pain","volume":"8","author":"Chang","year":"2013","journal-title":"J. Neuroimmune Pharmacol."},{"issue":"4","key":"10.1016\/j.schres.2026.01.006_bb0075","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1002\/mrm.22641","article-title":"Partial volume correction of multiple inversion time arterial spin labeling MRI data","volume":"65","author":"Chappell","year":"2011","journal-title":"Magn. Reson. Med."},{"key":"10.1016\/j.schres.2026.01.006_bb0080","doi-asserted-by":"crossref","DOI":"10.1016\/j.pnpbp.2023.110926","article-title":"Role of the immune-kynurenine pathway in treatment-resistant schizophrenia","volume":"130","author":"Chen","year":"2024","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"issue":"1","key":"10.1016\/j.schres.2026.01.006_bb0085","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/0920-9964(93)90077-V","article-title":"Serum immunoglobulin levels in Chinese male schizophrenics","volume":"10","author":"Chong-Thim","year":"1993","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.schres.2026.01.006_bb0090","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/j.schres.2017.08.051","article-title":"Gliadin-related antibodies in schizophrenia","volume":"195","author":"Cihakova","year":"2018","journal-title":"Schizophr. Res."},{"issue":"2","key":"10.1016\/j.schres.2026.01.006_bb0095","first-page":"129","article-title":"Pain assessment: global use of the Brief Pain Inventory","volume":"23","author":"Cleeland","year":"1994","journal-title":"Ann. Acad. Med. Singapore"},{"key":"10.1016\/j.schres.2026.01.006_bb0100","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.cca.2015.02.029","article-title":"Schizophrenia and bipolar disorder: the road from similarities and clinical heterogeneity to neurobiological types","volume":"449","author":"Dacquino","year":"2015","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.schres.2026.01.006_bb0105","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.schres.2023.02.027","article-title":"The relationship of peripheral inflammation with antibodies to gliadin (AGA IgG) in persons with schizophrenia","volume":"256","author":"Daniels","year":"2023","journal-title":"Schizophr. Res."},{"issue":"5","key":"10.1016\/j.schres.2026.01.006_bb0110","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1046\/j.1365-2796.1997.00200.x","article-title":"Schizophrenic symptoms and SPECT abnormalities in a coeliac patient: regression after a gluten-free diet","volume":"242","author":"De Santis","year":"1997","journal-title":"J. Intern. Med."},{"issue":"26","key":"10.1016\/j.schres.2026.01.006_bb0115","doi-asserted-by":"crossref","first-page":"6344","DOI":"10.1016\/j.cell.2021.11.019","article-title":"A genetically defined insula-brainstem circuit selectively controls motivational vigor","volume":"184","author":"Deng","year":"2021","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.schres.2026.01.006_bb0120","first-page":"66","article-title":"Assessment of capacity to give consent to research participation: state-of-the-art and beyond","volume":"1","author":"DeRenzo","year":"1998","journal-title":"J. Health Care Law Policy"},{"issue":"1","key":"10.1016\/j.schres.2026.01.006_bb0125","first-page":"134","article-title":"Inflammatory markers in recent onset psychosis and chronic schizophrenia","volume":"42","author":"Dickerson","year":"2016","journal-title":"Schizophr. Bull."},{"issue":"2","key":"10.1016\/j.schres.2026.01.006_bb0130","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1111\/j.1600-0447.1966.tb01920.x","article-title":"Cereals and schizophrenia data and hypothesis","volume":"42","author":"Dohan","year":"1966","journal-title":"Acta Psychiatr. Scand."},{"issue":"1","key":"10.1016\/j.schres.2026.01.006_bb0135","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1600-0447.1966.tb01912.x","article-title":"Wartime changes in hospital admissions for schizophrenia. A comparison of admission for schizophrenia and other psychoses in six countries during World War II","volume":"42","author":"Dohan","year":"1966","journal-title":"Acta Psychiatr. Scand."},{"issue":"522","key":"10.1016\/j.schres.2026.01.006_bb0140","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1192\/bjp.115.522.595","article-title":"Relapsed schizophrenics: more rapid improvement on a milk- and cereal-free diet","volume":"115","author":"Dohan","year":"1969","journal-title":"Br. J. Psychiatry"},{"issue":"3","key":"10.1016\/j.schres.2026.01.006_bb0145","first-page":"385","article-title":"Is schizophrenia rare if grain is rare?","volume":"19","author":"Dohan","year":"1984","journal-title":"Biol. Psychiatry"},{"issue":"3","key":"10.1016\/j.schres.2026.01.006_bb0150","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1176\/appi.ajp.163.3.521","article-title":"Association of schizophrenia and autoimmune diseases: linkage of Danish national registers","volume":"163","author":"Eaton","year":"2006","journal-title":"Am. J. Psychiatry"},{"issue":"10","key":"10.1016\/j.schres.2026.01.006_bb0155","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1016\/j.biopsych.2013.01.001","article-title":"Inflammatory cytokines and neurological and neurocognitive alterations in the course of schizophrenia","volume":"73","author":"Fineberg","year":"2013","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.schres.2026.01.006_bb0160","series-title":"Structured clinical interview for DSM-IV axis II personality disorders","author":"First","year":"1997"},{"issue":"3","key":"10.1016\/j.schres.2026.01.006_bb0165","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1097\/JCP.0000000000001197","article-title":"The effects of a gluten-free diet on immune markers and kynurenic acid pathway metabolites in patients with schizophrenia positive for antigliadin antibodies immunoglobulin G","volume":"40","author":"Friendshuh","year":"2020","journal-title":"J. Clin. Psychopharmacol."},{"issue":"1","key":"10.1016\/j.schres.2026.01.006_bb0170","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1002\/wps.20700","article-title":"The interplay among psychopathology, personal resources, context-related factors and real-life functioning in schizophrenia: stability in relationships after 4 years and differences in network structure between recovered and non-recovered patients","volume":"19","author":"Galderisi","year":"2020","journal-title":"World Psychiatry"},{"issue":"7","key":"10.1016\/j.schres.2026.01.006_bb0175","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1080\/14737175.2022.2092402","article-title":"Updated perspectives on the clinical significance of negative symptoms in patients with schizophrenia","volume":"22","author":"Giordano","year":"2022","journal-title":"Expert Rev. Neurother."},{"issue":"1","key":"10.1016\/j.schres.2026.01.006_bb0180","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1038\/s41537-025-00659-1","article-title":"Feasibility of a digital therapeutic for experiential negative symptoms of schizophrenia: results from an exploratory study","volume":"11","author":"Goenjian","year":"2025","journal-title":"Schizophrenia (Heidelb)"},{"key":"10.1016\/j.schres.2026.01.006_bb0185","doi-asserted-by":"crossref","DOI":"10.1016\/j.psychres.2019.112509","article-title":"Predicting real-world functioning in outpatients with schizophrenia: Role of inflammation and psychopathology","volume":"280","author":"Gonzalez-Blanco","year":"2019","journal-title":"Psychiatry Res."},{"issue":"3","key":"10.1016\/j.schres.2026.01.006_bb0190","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S0920-9964(96)00099-0","article-title":"The relationship between schizophrenia and irritable bowel syndrome (IBS)","volume":"23","author":"Gupta","year":"1997","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.schres.2026.01.006_bb0195","series-title":"U. S. Dept. of Health, Education, and Welfare, Public Health Service, Alcohol, Drug Abuse, and Mental Health Administration, National Institute of Mental Health, Psychopharmacology Research Branch, Division of Extramural Research Programs","article-title":"ECDEU assessment manual for psychopharmacology, revised (Rev. ed.)","author":"Guy","year":"1976"},{"issue":"9442","key":"10.1016\/j.schres.2026.01.006_bb0200","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1016\/S0140-6736(04)17181-X","article-title":"Schizophrenia","volume":"364","author":"Hemmings","year":"2004","journal-title":"Lancet"},{"issue":"9","key":"10.1016\/j.schres.2026.01.006_bb0205","doi-asserted-by":"crossref","DOI":"10.3390\/brainsci12091154","article-title":"The interrelation between Interleukin-2 and Schizophrenia","volume":"12","author":"Huang","year":"2022","journal-title":"Brain Sci."},{"issue":"1\u20133","key":"10.1016\/j.schres.2026.01.006_bb0210","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/j.schres.2012.06.011","article-title":"A gluten-free diet in people with schizophrenia and anti-tissue transglutaminase or anti-gliadin antibodies","volume":"140","author":"Jackson","year":"2012","journal-title":"Schizophr. Res."},{"issue":"2\u20133","key":"10.1016\/j.schres.2026.01.006_bb0215","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.schres.2014.09.023","article-title":"Gluten sensitivity and relationship to psychiatric symptoms in people with schizophrenia","volume":"159","author":"Jackson","year":"2014","journal-title":"Schizophr. Res."},{"issue":"2\u20133","key":"10.1016\/j.schres.2026.01.006_bb0220","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.schres.2003.09.011","article-title":"The brief assessment of cognition in schizophrenia: reliability, sensitivity, and comparison with a standard neurocognitive battery","volume":"68","author":"Keefe","year":"2004","journal-title":"Schizophr. Res."},{"issue":"2","key":"10.1016\/j.schres.2026.01.006_bb0225","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1080\/13803390500360539","article-title":"The relationship of the Brief Assessment of Cognition in Schizophrenia (BACS) to functional capacity and real-world functional outcome","volume":"28","author":"Keefe","year":"2006","journal-title":"J. Clin. Exp. Neuropsychol."},{"key":"10.1016\/j.schres.2026.01.006_bb0230","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.schres.2021.12.028","article-title":"Can the current schizophrenia construct endure?","volume":"242","author":"Kelly","year":"2022","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.schres.2026.01.006_bb0235","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.bbi.2017.10.020","article-title":"Anti gliadin antibodies (AGA IgG) related to peripheral inflammation in schizophrenia","volume":"69","author":"Kelly","year":"2018","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.schres.2026.01.006_bb0240","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/j.psychres.2018.09.006","article-title":"Increased circulating regulatory T cells in medicated people with schizophrenia","volume":"269","author":"Kelly","year":"2018","journal-title":"Psychiatry Res."},{"issue":"4","key":"10.1016\/j.schres.2026.01.006_bb0245","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1503\/jpn.180174","article-title":"Randomized controlled trial of a gluten-free diet in patients with schizophrenia positive for antigliadin antibodies (AGA IgG): a pilot feasibility study","volume":"44","author":"Kelly","year":"2019","journal-title":"J. Psychiatry Neurosci."},{"key":"10.1016\/j.schres.2026.01.006_bb0250","doi-asserted-by":"crossref","DOI":"10.1001\/jamapsychiatry.2019.1200","article-title":"From many to one to many-the search for causes of psychiatric illness","author":"Kendler","year":"2019","journal-title":"JAMA Psychiatry"},{"issue":"2","key":"10.1016\/j.schres.2026.01.006_bb0255","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1176\/appi.ajp.2007.07010043","article-title":"The MATRICS consensus cognitive battery, part 2: co-norming and standardization","volume":"165","author":"Kern","year":"2008","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.schres.2026.01.006_bb0260","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.neuroimage.2015.10.050","article-title":"The common genetic influence over processing speed and white matter microstructure: evidence from the Old Order Amish and Human Connectome Projects","volume":"125","author":"Kochunov","year":"2016","journal-title":"Neuroimage"},{"issue":"25","key":"10.1016\/j.schres.2026.01.006_bb0265","doi-asserted-by":"crossref","first-page":"6211","DOI":"10.1016\/j.cell.2021.11.021","article-title":"Insular cortex neurons encode and retrieve specific immune responses","volume":"184","author":"Koren","year":"2021","journal-title":"Cell"},{"issue":"5","key":"10.1016\/j.schres.2026.01.006_bb0270","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1172\/JCI104975","article-title":"Abnormal tryptophan metabolism in patients with adult celiac disease, with evidence for deficiency of vitamin B6","volume":"43","author":"Kowlessar","year":"1964","journal-title":"J. Clin. Invest."},{"issue":"2","key":"10.1016\/j.schres.2026.01.006_bb0275","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1176\/appi.ajp.2012.12010109","article-title":"The clinical assessment interview for negative symptoms (CAINS): final development and validation","volume":"170","author":"Kring","year":"2013","journal-title":"Am. J. Psychiatry"},{"issue":"2\u20133","key":"10.1016\/j.schres.2026.01.006_bb0280","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/j.schres.2013.12.001","article-title":"Biomarkers of gluten sensitivity in patients with non-affective psychosis: a meta-analysis","volume":"152","author":"Lachance","year":"2014","journal-title":"Schizophr. Res."},{"issue":"1","key":"10.1016\/j.schres.2026.01.006_bb0285","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1038\/s41398-021-01196-y","article-title":"The prevalence of depressive and anxiety symptoms and their associations with quality of life among clinically stable older patients with psychiatric disorders during the COVID-19 pandemic","volume":"11","author":"Li","year":"2021","journal-title":"Transl. Psychiatry"},{"issue":"2","key":"10.1016\/j.schres.2026.01.006_bb0290","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1097\/01.pra.0000369971.64908.dc","article-title":"How sequential studies inform drug development: evaluating the effect of food intake on optimal bioavailability of ziprasidone","volume":"16","author":"Lincoln","year":"2010","journal-title":"J. Psychiatr. Pract."},{"key":"10.1016\/j.schres.2026.01.006_bb0295","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.bbi.2021.09.007","article-title":"Anterior insula morphology and vulnerability to psychopathology-related symptoms in response to acute inflammation","volume":"99","author":"Mansson","year":"2022","journal-title":"Brain Behav. Immun."},{"issue":"1","key":"10.1016\/j.schres.2026.01.006_bb0300","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1097\/00005650-199401000-00004","article-title":"The MOS 36-item Short-Form Health Survey (SF-36): III. Tests of data quality, scaling assumptions, and reliability across diverse patient groups","volume":"32","author":"McHorney","year":"1994","journal-title":"Med. Care"},{"issue":"7","key":"10.1016\/j.schres.2026.01.006_bb0305","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1037\/abn0000461","article-title":"From neuroimaging to daily functioning: a multimethod analysis of reward anticipation in people with schizophrenia","volume":"128","author":"Moran","year":"2019","journal-title":"J. Abnorm. Psychol."},{"issue":"5","key":"10.1016\/j.schres.2026.01.006_bb0310","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1001\/jamapsychiatry.2020.4614","article-title":"Factors associated with real-life functioning in persons with schizophrenia in a 4-year follow-up study of the italian network for research on psychoses","volume":"78","author":"Mucci","year":"2021","journal-title":"JAMA Psychiatry"},{"issue":"16","key":"10.1016\/j.schres.2026.01.006_bb0315","doi-asserted-by":"crossref","DOI":"10.3390\/cells12162099","article-title":"Microglia and other cellular mediators of immunological dysfunction in schizophrenia: a narrative synthesis of clinical findings","volume":"12","author":"Nguyen","year":"2023","journal-title":"Cells"},{"issue":"2","key":"10.1016\/j.schres.2026.01.006_bb0320","first-page":"82","article-title":"Health benefits and adverse effects of a gluten-free diet in non-celiac disease patients","volume":"14","author":"Niland","year":"2018","journal-title":"Gastroenterol Hepatol (N Y)"},{"issue":"2","key":"10.1016\/j.schres.2026.01.006_bb0325","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1176\/appi.ajp.2007.07010042","article-title":"The MATRICS consensus cognitive battery, part 1: test selection, reliability, and validity","volume":"165","author":"Nuechterlein","year":"2008","journal-title":"Am. J. Psychiatry"},{"issue":"7","key":"10.1016\/j.schres.2026.01.006_bb0330","doi-asserted-by":"crossref","first-page":"509","DOI":"10.3109\/15622975.2012.747699","article-title":"Elevated gliadin antibody levels in individuals with schizophrenia","volume":"14","author":"Okusaga","year":"2013","journal-title":"World J. Biol. Psychiatry"},{"issue":"8","key":"10.1016\/j.schres.2026.01.006_bb0335","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1097\/PSY.0000000000000352","article-title":"Kynurenine and tryptophan levels in patients with schizophrenia and elevated antigliadin immunoglobulin G antibodies","volume":"78","author":"Okusaga","year":"2016","journal-title":"Psychosom. Med."},{"issue":"4","key":"10.1016\/j.schres.2026.01.006_bb0340","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1176\/appi.ajp.20240048","article-title":"Kynurenic acid and promotion of activity-dependent synapse elimination in schizophrenia","volume":"182","author":"Orhan","year":"2025","journal-title":"Am. J. Psychiatry"},{"issue":"5","key":"10.1016\/j.schres.2026.01.006_bb0345","first-page":"627","article-title":"Lack of effect of a gluten-free diet on neuroleptic blood levels in schizophrenic patients","volume":"17","author":"Osborne","year":"1982","journal-title":"Biol. Psychiatry"},{"issue":"3","key":"10.1016\/j.schres.2026.01.006_bb0350","doi-asserted-by":"crossref","first-page":"799","DOI":"10.2466\/pr0.1962.10.3.799","article-title":"The brief psychiatric rating scale","volume":"10","author":"Overall","year":"1962","journal-title":"Psychol. Rep."},{"issue":"1","key":"10.1016\/j.schres.2026.01.006_bb0355","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1177\/15598276211049345","article-title":"Gluten, inflammation, and neurodegeneration","volume":"16","author":"Philip","year":"2022","journal-title":"Am. J. Lifestyle Med."},{"key":"10.1016\/j.schres.2026.01.006_bb0360","doi-asserted-by":"crossref","DOI":"10.1001\/jamapsychiatry.2021.0022","article-title":"Three important considerations for studies examining pathophysiological pathways in psychiatric illness: in-depth phenotyping, biological assessment, and causal inferences","author":"Phillips","year":"2021","journal-title":"JAMA Psychiatry"},{"issue":"4","key":"10.1016\/j.schres.2026.01.006_bb0365","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1093\/schbul\/sbw221","article-title":"Kynurenic acid in schizophrenia: a systematic review and meta-analysis","volume":"43","author":"Plitman","year":"2017","journal-title":"Schizophr. Bull."},{"issue":"6","key":"10.1016\/j.schres.2026.01.006_bb0370","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1124\/pharmrev.124.000239","article-title":"Neuroactive kynurenines as pharmacological targets: new experimental tools and exciting therapeutic opportunities","volume":"76","author":"Pocivavsek","year":"2024","journal-title":"Pharmacol. Rev."},{"issue":"9","key":"10.1016\/j.schres.2026.01.006_bb0375","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1176\/ajp.138.9.1208","article-title":"Wheat gluten challenge in schizophrenic patients","volume":"138","author":"Potkin","year":"1981","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.schres.2026.01.006_bb0380","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1007\/7854_2018_48","article-title":"Deconstructing schizophrenia: advances in preclinical models for biomarker identification","volume":"40","author":"Pratt","year":"2018","journal-title":"Curr. Top. Behav. Neurosci."},{"key":"10.1016\/j.schres.2026.01.006_bb0385","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.ab.2016.11.007","article-title":"Creatine in the central nervous system: From magnetic resonance spectroscopy to creatine deficiencies","volume":"529","author":"Rackayova","year":"2017","journal-title":"Anal. Biochem."},{"issue":"1","key":"10.1016\/j.schres.2026.01.006_bb0390","first-page":"122","article-title":"Discussion: recent developments in ascertainment and scaling of the BPRS","volume":"24","author":"Raskin","year":"1988","journal-title":"Psychopharmacol. Bull."},{"issue":"1","key":"10.1016\/j.schres.2026.01.006_bb0395","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1023\/A:1008841022998","article-title":"Reliability and validity of the gastrointestinal symptom rating scale in patients with gastroesophageal reflux disease","volume":"7","author":"Revicki","year":"1998","journal-title":"Qual. Life Res."},{"issue":"11","key":"10.1016\/j.schres.2026.01.006_bb0400","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1176\/ajp.135.11.1417","article-title":"Another look at gluten in schizophrenia","volume":"135","author":"Rice","year":"1978","journal-title":"Am. J. Psychiatry"},{"issue":"2","key":"10.1016\/j.schres.2026.01.006_bb0405","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1001\/jamapsychiatry.2015.2680","article-title":"Frontal glutamate and gamma-aminobutyric acid levels and their associations with mismatch negativity and digit sequencing task performance in schizophrenia","volume":"73","author":"Rowland","year":"2016","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.schres.2026.01.006_bb0410","doi-asserted-by":"crossref","first-page":"104","DOI":"10.3389\/fpsyt.2017.00104","article-title":"Antigliadin antibodies (AGA IgG) are related to neurochemistry in schizophrenia","volume":"8","author":"Rowland","year":"2017","journal-title":"Front. Psych."},{"issue":"3","key":"10.1016\/j.schres.2026.01.006_bb0415","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1038\/s41380-022-01924-w","article-title":"Inflammation and cognition in severe mental illness: patterns of covariation and subgroups","volume":"28","author":"Saether","year":"2023","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.schres.2026.01.006_bb0420","series-title":"Neuropsychopharmacology, ACNP 62nd Annual Meeting: Poster Abstracts","first-page":"355","article-title":"Regulatory T cells correlate negatively with serum kynurenine in schizophrenia persons with positive serum anti-gliadin antibodies (AGA)","volume":"48(1)","author":"Salem","year":"2023"},{"key":"10.1016\/j.schres.2026.01.006_bb0425","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.schres.2025.08.008","article-title":"T cells are associated with negative symptoms in persons with anti-gliadin antibody positive schizophrenia and related disorders","volume":"284","author":"Salem","year":"2025","journal-title":"Schizophr. Res."},{"issue":"12","key":"10.1016\/j.schres.2026.01.006_bb0430","doi-asserted-by":"crossref","first-page":"1820","DOI":"10.1002\/mds.22681","article-title":"Development of a brief ataxia rating scale (BARS) based on a modified form of the ICARS","volume":"24","author":"Schmahmann","year":"2009","journal-title":"Mov. Disord."},{"issue":"7","key":"10.1016\/j.schres.2026.01.006_bb0435","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1038\/nrn3257","article-title":"Kynurenines in the mammalian brain: when physiology meets pathology","volume":"13","author":"Schwarcz","year":"2012","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.schres.2026.01.006_bb0440","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.bbi.2014.09.009","article-title":"IgG dynamics of dietary antigens point to cerebrospinal fluid barrier or flow dysfunction in first-episode schizophrenia","volume":"44","author":"Severance","year":"2015","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.schres.2026.01.006_bb0445","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.schres.2020.03.068","article-title":"Insula functional connectivity in schizophrenia","volume":"220","author":"Sheffield","year":"2020","journal-title":"Schizophr. Res."},{"issue":"1 Pt 1","key":"10.1016\/j.schres.2026.01.006_bb0450","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1542\/peds.23.1.132","article-title":"Celiac disease","volume":"23","author":"Sheldon","year":"1959","journal-title":"Pediatrics"},{"issue":"5","key":"10.1016\/j.schres.2026.01.006_bb0455","doi-asserted-by":"crossref","first-page":"538","DOI":"10.3109\/08820139.2012.685537","article-title":"Spectrum of autoantibodies in Tunisian psychiatric inpatients","volume":"41","author":"Sidhom","year":"2012","journal-title":"Immunol. Invest."},{"key":"10.1016\/j.schres.2026.01.006_bb0460","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/j.1600-0447.1970.tb02066.x","article-title":"A rating scale for extrapyramidal side effects","volume":"212","author":"Simpson","year":"1970","journal-title":"Acta Psychiatr.Scand.Suppl"},{"issue":"4225","key":"10.1016\/j.schres.2026.01.006_bb0465","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1126\/science.1246624","article-title":"Wheat gluten as a pathogenic factor in schizophrenia","volume":"191","author":"Singh","year":"1976","journal-title":"Science"},{"issue":"3","key":"10.1016\/j.schres.2026.01.006_bb0470","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1001\/archpsyc.1982.04290030055010","article-title":"Effects of gluten on schizophrenics","volume":"39","author":"Storms","year":"1982","journal-title":"Arch. Gen. Psychiatry"},{"issue":"1","key":"10.1016\/j.schres.2026.01.006_bb0475","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/s00406-021-01260-0","article-title":"The impact of the COVID-19 pandemic on negative symptoms in individuals at clinical high-risk for psychosis and outpatients with chronic schizophrenia","volume":"272","author":"Strauss","year":"2022","journal-title":"Eur. Arch. Psychiatry Clin. Neurosci."},{"key":"10.1016\/j.schres.2026.01.006_bb0480","article-title":"\"Schizophrenia\" does not exist","volume":"352","author":"van Os","year":"2016","journal-title":"BMJ"},{"key":"10.1016\/j.schres.2026.01.006_bb0485","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1192\/bjp.148.4.447","article-title":"A double-blind gluten-free\/gluten-load controlled trial in a secure ward population","volume":"148","author":"Vlissides","year":"1986","journal-title":"Br. J. Psychiatry"},{"issue":"2","key":"10.1016\/j.schres.2026.01.006_bb0490","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1038\/npp.2016.172","article-title":"Altered glutamate and regional cerebral blood flow levels in schizophrenia: A (1)H-MRS and pCASL study","volume":"42","author":"Wijtenburg","year":"2017","journal-title":"Neuropsychopharmacology"}],"container-title":["Schizophrenia Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S092099642600006X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S092099642600006X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,21]],"date-time":"2026-06-21T03:56:02Z","timestamp":1782014162000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S092099642600006X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":98,"alternative-id":["S092099642600006X"],"URL":"https:\/\/doi.org\/10.1016\/j.schres.2026.01.006","relation":{},"ISSN":["0920-9964"],"issn-type":[{"value":"0920-9964","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Randomized double-blind inpatient study of a gluten-free diet for negative symptoms in people with schizophrenia","name":"articletitle","label":"Article Title"},{"value":"Schizophrenia Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.schres.2026.01.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}